Proteomics

Dataset Information

0

LC-MS/MS of SCA3 knock-in mouse cortex, cerebellum, and axons


ABSTRACT: Spinocerebellar ataxia type 3 (SCA3/MJD) has a polyQ etiology but, the current knowledge on molecular processes and proteins involved in pathogenesis is insufficient. Due to its proteolytic function, Ataxin-3 can influence other proteins, yet the global picture of crucial proteins and pathways in SCA3 was not investigated previously. Here, we explored molecular SCA3 mechanism by interdisciplinary research paradigm combining SCA3 knock-in model, behavior, MRI, brain proteomics, precise axonal proteomics, neuronal energy recordings, labeling of vesicles, and inclusions and focusing in axonal compartment. Using the global proteomics, we found dysregulation of protein homeostasis over the entire disease progression. The early SCA3 phase was associated with reduced body weight gain, the presence of the number of dysregulated proteins related to metabolism and mitochondria, and an altered profile of oxygen consumption rate in neurons. Moreover, the early phase presented alterations of protein metabolism, cytoskeletal architecture, axonal and synaptic proteins. Protein dysregulations indicated that the compartment involved in SCA3 pathogenesis next to the mitochondria are also neuronal processes and axons in particular. To confirm that the axon is one of the central compartments in SCA3 pathogenesis, we performed targeted proteomics on axons and somatodendritic compartments. We revealed highly increased axonal localization of protein synthesis machinery, including ribosomes, translation factors, and RNA binding proteins, while the level of proteins responsible for cellular transport and mitochondria was decreased. In summary, the SCA3 disease mechanism is based on the broad influence of mutant ataxin-3 on the neuronal proteome. Processes central in our SCA3 model include disturbed localization of proteins between axonal and somatodendritic compartment, early neuronal energy deficit, altered neuronal cytoskeletal structure, an overabundance of protein synthetic machinery in axons.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain

SUBMITTER: Lukasz Marczak  

LAB HEAD: Lukasz Marczak

PROVIDER: PXD024945 | Pride | 2021-04-08

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
10mo_C57_cere.raw Raw
10mo_C57_ctx.raw Raw
12c571cere.raw Raw
12c571ctx.raw Raw
12c572cere.raw Raw
Items per page:
1 - 5 of 241

Similar Datasets

2014-12-01 | GSE59506 | GEO
2021-06-01 | PXD026229 | Pride
2010-11-23 | E-GEOD-22638 | biostudies-arrayexpress
2009-01-14 | E-GEOD-11730 | biostudies-arrayexpress
2010-01-30 | E-GEOD-13788 | biostudies-arrayexpress
2021-11-04 | PXD021876 | Pride
2020-07-27 | GSE147607 | GEO
2016-07-29 | E-GEOD-84975 | biostudies-arrayexpress
2010-11-23 | GSE22638 | GEO
2016-06-16 | E-GEOD-79352 | biostudies-arrayexpress